This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Oct 18;7(12):683.

doi: 10.1038/nrrheum.2011.163.

Rheumatoid arthritis: Tocilizumab is efficacious in active RA as little as 1 week after treatment

PMID: 22009330
DOI: 10.1038/nrrheum.2011.163

Comment

Rheumatoid arthritis: Tocilizumab is efficacious in active RA as little as 1 week after treatment

David Killock. Nat Rev Rheumatol. 2011.

. 2011 Oct 18;7(12):683.

doi: 10.1038/nrrheum.2011.163.

Author

PMID: 22009330
DOI: 10.1038/nrrheum.2011.163

No abstract available

PubMed Disclaimer

Comment on

Efficacy of tocilizumab in patients with moderate to severe active rheumatoid arthritis and a previous inadequate response to disease-modifying antirheumatic drugs: the ROSE study.
Yazici Y, Curtis JR, Ince A, Baraf H, Malamet RL, Teng LL, Kavanaugh A. Yazici Y, et al. Ann Rheum Dis. 2012 Feb;71(2):198-205. doi: 10.1136/ard.2010.148700. Epub 2011 Sep 26. Ann Rheum Dis. 2012. PMID: 21949007 Clinical Trial.

References

1. Ann Rheum Dis. 2012 Feb;71(2):198-205 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.